Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-04-20

Clinical Trial Update: Adenosine as an Adjunct to Blood Cardioplegia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating adenosine added to blood cardioplegia for myocardial protection during cardiac surgery; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Adenosine (Adenosine)

Snippet

Sponsor: Amphia Hospital | Conditions: Pathological Processes, Cardiomyopathies | Phase 2 | Status: UNKNOWN